Korean J Hematol 1995; 30(1):
Published online March 31, 1995
© The Korean Society of Hematology
한지숙, 이종인, 민유홍, 고윤웅
연세대학교 의과대학 내과학교실
Background: There was a tendency toward increasing incidence of malignancies and
double primary cancers associated with hematologic malignailcies. With few reports
about the double primary cancers associated with hematologic malignancies, we
investigated the incidence, clinical characteristics, and therapeutic outcomes of double
primary cancers associated with hematologic malignancies.
Methods: During the 20 years(1973∼1992), 58,225 malignancies, 4,181 hematologic
malignancies, and 449 double primary malignancies were registered at the Severance
Hospital. Among them, 15 cases of double primary cancels associated with hematologic
malignancies, proved by tissue biopsy or surgery, were analyzed.
Results :
1) There was a tendency toward increasing incidence of double primary cancers
associated with hematologic malignancies.
2) The incidence of double primary cancers associated with hematologic malignancies
among all malignancies and among all double primary malignancies were 0.03% and
3.34%, respectively.
3) There was no difference in sex distribution and the median age was 55 years.
4) Among the double primary cancers associated with hematologic malignancies,
malignant lymphomas were the most common hematologic malignancies(11 cases).
5) The ratio between synchronous and metachronous cancers was 6:9, and the median
time interval was 1.7 years in 9 metachronous cases, in whom 7 cases were treated
with chemotherapy or radiotherapy.
6) There was no difference in the incidence of ABO blood types.
7) Among the 9 follow-up cases, 3 cases were under medical treatment and the
median survival time from the secondary malignancy was 9 months in 6 cases.
Conclusion: Multiple primary cancers associated with hematologic malignancies need
further speculation for the relations with chemotherapy or radiotherapy and also more
understanding to recognize and treat it properly should be required.
Keywords Double primary cancers, Hematologic malignancies
Korean J Hematol 1995; 30(1): 111-119
Published online March 31, 1995
Copyright © The Korean Society of Hematology.
한지숙, 이종인, 민유홍, 고윤웅
연세대학교 의과대학 내과학교실
Jee Sook Hahn, Chong In Lee, Yoo Hong Min, Yun Woong Ko
Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea
Background: There was a tendency toward increasing incidence of malignancies and
double primary cancers associated with hematologic malignailcies. With few reports
about the double primary cancers associated with hematologic malignancies, we
investigated the incidence, clinical characteristics, and therapeutic outcomes of double
primary cancers associated with hematologic malignancies.
Methods: During the 20 years(1973∼1992), 58,225 malignancies, 4,181 hematologic
malignancies, and 449 double primary malignancies were registered at the Severance
Hospital. Among them, 15 cases of double primary cancels associated with hematologic
malignancies, proved by tissue biopsy or surgery, were analyzed.
Results :
1) There was a tendency toward increasing incidence of double primary cancers
associated with hematologic malignancies.
2) The incidence of double primary cancers associated with hematologic malignancies
among all malignancies and among all double primary malignancies were 0.03% and
3.34%, respectively.
3) There was no difference in sex distribution and the median age was 55 years.
4) Among the double primary cancers associated with hematologic malignancies,
malignant lymphomas were the most common hematologic malignancies(11 cases).
5) The ratio between synchronous and metachronous cancers was 6:9, and the median
time interval was 1.7 years in 9 metachronous cases, in whom 7 cases were treated
with chemotherapy or radiotherapy.
6) There was no difference in the incidence of ABO blood types.
7) Among the 9 follow-up cases, 3 cases were under medical treatment and the
median survival time from the secondary malignancy was 9 months in 6 cases.
Conclusion: Multiple primary cancers associated with hematologic malignancies need
further speculation for the relations with chemotherapy or radiotherapy and also more
understanding to recognize and treat it properly should be required.
Keywords: Double primary cancers, Hematologic malignancies
Sang Mee Hwang
Blood Res 2024; 59():Adel El-Badrawy, Nada Elbadrawy
Blood Res 2022; 57(3): 216-222Jae-Wook Lee, Kyong-Won Bang, Pil-Sang Jang, Nak-Gyun Chung, Bin Cho, Dae-Chul Jeong, Hack-Ki Kim, Soo-Ah Im, and Gye-Yeon Lim
Korean J Hematol 2010; 45(1): 62-65